NCT00657774 A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands Status COMPLETED Phase PHASE1
NCT00652392 Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM Status COMPLETED Phase PHASE3
NCT00652002 Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5 Status COMPLETED Phase PHASE3
NCT00651651 Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5 Status COMPLETED Phase PHASE3
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults Status COMPLETED Phase PHASE3
NCT00646789 A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019) Status COMPLETED Phase PHASE1
NCT00646529 Long-Term Safety of Symbicort in Asthmatic Children - SAPLING Status COMPLETED Phase PHASE3
NCT00646321 Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT Status COMPLETED Phase PHASE3
NCT00643578 Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay Status COMPLETED Phase NA
NCT00642616 Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease Status TERMINATED Phase PHASE3